Prologis price target raised to $100 from $97 at Scotiabank
Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PLD:
Disclaimer & DisclosureReport an Issue
Prologis Issues $1.25 Billion in Senior Notes
Prologis price target lowered to $120 from $126 at Baird
Prologis price target lowered to $120 from $123 at Truist
Prologis price target lowered to $119 from $132 at Barclays
Prologis price target lowered to $117 from $128 at RBC Capital
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
22 minutes ago
- Business Insider
UnitedHealth Stock (UNH) Tumbles 50% YTD; Here's How to Buy the Dip Without the Risk
UnitedHealth Group (UNH), the largest U.S. health insurer, recently suffered one of its worst stock plunges, down over 50% year-to-date following weak Q1 earnings and a lower full-year outlook. For long-term investors, this dramatic dip may present a buying opportunity, especially through exchange-traded funds (ETFs) that offer diversified exposure to UNH without the risk of holding the stock directly. Thus, investors seeking exposure to UNH stock may consider the Harbor Health Care ETF (MEDI) and T. Rowe Price Health Care ETF (TMED). Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Let's take a deeper look at these two ETFs. Harbor Health Care ETF The MEDI ETF is an actively managed fund that targets long-term capital growth by investing in healthcare companies. The ETF provides exposure to UnitedHealth stock alongside other major players like Ascendis Pharma (ASND), Eli Lilly (LLY), and Legend Biotech (LEGN). Importantly, UNH accounts for 5.6% of the MEDI ETF's total holdings. Overall, the ETF has $16.24 million in assets under management (AUM). Also, it has an expense ratio of 0.8%. Over the past three months, the MEDI ETF has generated a return of 5%. On TipRanks, MEDI has a Strong Buy consensus rating based on 36 Buys and two Holds assigned in the last three months. At $37.67, the average MEDI ETF price target implies 42.79% upside potential. T. Rowe Price Health Care ETF The TMED ETF is an actively managed fund that aims to capture long-term growth opportunities in the healthcare sector, including pharmaceuticals, biotechnology, medical devices, and healthcare services. UNH stock constitutes 5.91% of the ETF's holdings. Apart from UnitedHealth, some of the top stocks in the TMED ETF are AbbVie (ABBV), Abbott (ABT), and Danaher (DHR). Overall, the ETF has $11.81 million in AUM. Also, it has an expense ratio of 0.44%. The TMED ETF has declined 5.35% in the past three months. Turning to Wall Street, the ETF has a Moderate Buy consensus rating. Of the 110 stocks held, 99 have Buys, 10 have Holds, and one Sell rating. At $33.65, the average TMED ETF price target implies a 41.31% upside potential. Concluding Thoughts ETFs provide indirect exposure to UNH stock, reducing risk compared to investing directly in the stock. Furthermore, ETFs are a liquid and transparent way to participate in the market. Investors seeking ETF recommendations might consider MEDI and TMED, as these ETFs offer exposure to UnitedHealth stock.
Business Insider
22 minutes ago
- Business Insider
IGO (IPGDF) Receives a Sell from UBS
In a report released today, Levi Spry from UBS maintained a Sell rating on IGO, with a price target of A$4.80. The company's shares closed yesterday at $3.83. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Spry covers the Basic Materials sector, focusing on stocks such as Northern Star Resources Ltd, Evolution Mining , and Newmont Corporation CHESS. According to TipRanks, Spry has an average return of 12.0% and a 66.51% success rate on recommended stocks. In addition to UBS, IGO also received a Sell from Morgan Stanley's Rahul Anand in a report issued on August 8. However, yesterday, Citi maintained a Hold rating on IGO (Other OTC: IPGDF).
Business Insider
22 minutes ago
- Business Insider
UBS Reaffirms Their Sell Rating on Pilbara Minerals (PILBF)
In a report released today, Levi Spry from UBS maintained a Sell rating on Pilbara Minerals , with a price target of A$1.60. The company's shares closed yesterday at $1.49. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Spry covers the Basic Materials sector, focusing on stocks such as Northern Star Resources Ltd, Evolution Mining , and Newmont Corporation CHESS. According to TipRanks, Spry has an average return of 12.0% and a 66.51% success rate on recommended stocks. In addition to UBS, Pilbara Minerals also received a Sell from J.P. Morgan's Al Harvey in a report issued on July 30. However, yesterday, Citi maintained a Hold rating on Pilbara Minerals (Other OTC: PILBF). The company has a one-year high of $2.30 and a one-year low of $0.69. Currently, Pilbara Minerals has an average volume of 79.16K. Based on the recent corporate insider activity of 10 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of PILBF in relation to earlier this year.
